Snapshot from Aug 13, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities litigation

Embecta securities fraud class action

Analysis based on 6 articles · First reported Aug 10, 2026 · Last updated Aug 13, 2026

Sentiment
-30
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The lawsuit adds legal and reputational risk for Embecta, potentially pressuring its stock price and increasing uncertainty for investors. The market may react negatively to the allegations of misleading guidance, though the impact is likely limited given the early stage of litigation.

Medical devices

Rosen Law Firm has filed a securities class action lawsuit against Embecta on behalf of purchasers of Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements and concealed material adverse facts about its fiscal results, specifically that its guidance was misleading and unattainable. Embecta touted its pen needle business as 'incredibly resolute' shortly before missing expectations and cutting its 2026 fiscal guidance. Investors who purchased during the class period may be entitled to compensation. The lead plaintiff deadline is August 17, 2026.

100 Rosen Law Firm announced class action Embecta
stock
Embecta is the defendant in the securities fraud class action. The lawsuit alleges misleading guidance and could lead to financial damages and reputational harm.
Importance 100.0 Sentiment -40.0
priv
Rosen Law Firm filed the class action and is representing investors. The firm stands to gain from a successful settlement or judgment.
Importance 80.0 Sentiment 20.0
per
Lawrence Rosen is a founding partner of Rosen Law Firm and is involved in the case as counsel.
Importance 30.0 Sentiment 10.0
per
Philip Kim is an attorney at Rosen Law Firm and is listed as a contact for the class action.
Importance 30.0 Sentiment 10.0
Lawrence Rosen managing partner Philip Kim Lawrence Rosen is the founder and managing partner of Rosen Law Firm, where Philip Kim is a partner, and they actively c
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.